APO RESEARCH · REPORT
Blockchain In Pharmaceutical
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
Product & engineering
Understand the product.
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
Selected research
Industry Research
Blockchain In Pharmaceutical Industry Research Report 2026
Market perspective
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.
Read the full market overview
For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.
Report Scope
This report quantifies the global Blockchain In Pharmaceutical market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Blockchain In Pharmaceutical.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blockchain In Pharmaceutical Market by Company
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Blockchain In Pharmaceutical Segment by Type
Private Blockchain
Hybrid Blockchain
Blockchain In Pharmaceutical Segment by Application
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
Blockchain In Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blockchain In Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blockchain In Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blockchain In Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blockchain In Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Private Blockchain
- Hybrid Blockchain
Applications
- Supply Chain Logistics
- Drug Safety
- Clinical Trial Management
- IOMT & Cyber Security
Companies covered
- IBM
- AWS
- Microsoft
- SAP
- Chronicled
- Embleema
- FarmaTrust
- Guardtime Federal
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Blockchain In Pharmaceutical by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Private Blockchain
- 2.2.3 Hybrid Blockchain
- 2.3 Blockchain In Pharmaceutical by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Supply Chain Logistics
- 2.3.3 Drug Safety
- 2.3.4 Clinical Trial Management
- 2.3.5 IOMT & Cyber Security
- 2.4 Assumptions and Limitations
3 Blockchain In Pharmaceutical Breakdown Data by Type
- 3.1 Global Blockchain In Pharmaceutical Historic Market Size by Type (2021-2026)
- 3.2 Global Blockchain In Pharmaceutical Forecasted Market Size by Type (2027-2032)
4 Blockchain In Pharmaceutical Breakdown Data by Application
- 4.1 Global Blockchain In Pharmaceutical Historic Market Size by Application (2021-2026)
- 4.2 Global Blockchain In Pharmaceutical Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Blockchain In Pharmaceutical Market Perspective (2021-2032)
- 5.2 Global Blockchain In Pharmaceutical Growth Trends by Region
- 5.2.1 Global Blockchain In Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Blockchain In Pharmaceutical Historic Market Size by Region (2021-2026)
- 5.2.3 Blockchain In Pharmaceutical Forecasted Market Size by Region (2027-2032)
- 5.3 Blockchain In Pharmaceutical Market Dynamics
- 5.3.1 Blockchain In Pharmaceutical Industry Trends
- 5.3.2 Blockchain In Pharmaceutical Market Drivers
- 5.3.3 Blockchain In Pharmaceutical Market Challenges
- 5.3.4 Blockchain In Pharmaceutical Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Blockchain In Pharmaceutical Players by Revenue
- 6.1.1 Global Top Blockchain In Pharmaceutical Players by Revenue (2021-2026)
- 6.1.2 Global Blockchain In Pharmaceutical Revenue Market Share by Players (2021-2026)
- 6.2 Global Blockchain In Pharmaceutical Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blockchain In Pharmaceutical Head Office and Area Served
- 6.4 Global Blockchain In Pharmaceutical Players, Product Type & Application
- 6.5 Global Blockchain In Pharmaceutical Manufacturers Established Date
- 6.6 Global Blockchain In Pharmaceutical Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Blockchain In Pharmaceutical Market Size (2021-2032)
- 7.2 North America Blockchain In Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Blockchain In Pharmaceutical Market Size by Country (2021-2026)
- 7.4 North America Blockchain In Pharmaceutical Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Blockchain In Pharmaceutical Market Size (2021-2032)
- 8.2 Europe Blockchain In Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Blockchain In Pharmaceutical Market Size by Country (2021-2026)
- 8.4 Europe Blockchain In Pharmaceutical Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Blockchain In Pharmaceutical Market Size (2021-2032)
- 9.2 Asia-Pacific Blockchain In Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Blockchain In Pharmaceutical Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Blockchain In Pharmaceutical Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Blockchain In Pharmaceutical Market Size (2021-2032)
- 10.2 South America Blockchain In Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Blockchain In Pharmaceutical Market Size by Country (2021-2026)
- 10.4 South America Blockchain In Pharmaceutical Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Blockchain In Pharmaceutical Market Size (2021-2032)
- 11.2 Middle East & Africa Blockchain In Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Blockchain In Pharmaceutical Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Blockchain In Pharmaceutical Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IBM
- 12.1.1 IBM Company Information
- 12.1.2 IBM Business Overview
- 12.1.3 IBM Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.1.4 IBM Blockchain In Pharmaceutical Product Portfolio
- 12.1.5 IBM Recent Developments
- 12.2 AWS
- 12.2.1 AWS Company Information
- 12.2.2 AWS Business Overview
- 12.2.3 AWS Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.2.4 AWS Blockchain In Pharmaceutical Product Portfolio
- 12.2.5 AWS Recent Developments
- 12.3 Microsoft
- 12.3.1 Microsoft Company Information
- 12.3.2 Microsoft Business Overview
- 12.3.3 Microsoft Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.3.4 Microsoft Blockchain In Pharmaceutical Product Portfolio
- 12.3.5 Microsoft Recent Developments
- 12.4 SAP
- 12.4.1 SAP Company Information
- 12.4.2 SAP Business Overview
- 12.4.3 SAP Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.4.4 SAP Blockchain In Pharmaceutical Product Portfolio
- 12.4.5 SAP Recent Developments
- 12.5 Chronicled
- 12.5.1 Chronicled Company Information
- 12.5.2 Chronicled Business Overview
- 12.5.3 Chronicled Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.5.4 Chronicled Blockchain In Pharmaceutical Product Portfolio
- 12.5.5 Chronicled Recent Developments
- 12.6 Embleema
- 12.6.1 Embleema Company Information
- 12.6.2 Embleema Business Overview
- 12.6.3 Embleema Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.6.4 Embleema Blockchain In Pharmaceutical Product Portfolio
- 12.6.5 Embleema Recent Developments
- 12.7 FarmaTrust
- 12.7.1 FarmaTrust Company Information
- 12.7.2 FarmaTrust Business Overview
- 12.7.3 FarmaTrust Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.7.4 FarmaTrust Blockchain In Pharmaceutical Product Portfolio
- 12.7.5 FarmaTrust Recent Developments
- 12.8 Guardtime Federal
- 12.8.1 Guardtime Federal Company Information
- 12.8.2 Guardtime Federal Business Overview
- 12.8.3 Guardtime Federal Revenue in Blockchain In Pharmaceutical Business (2021-2026)
- 12.8.4 Guardtime Federal Blockchain In Pharmaceutical Product Portfolio
- 12.8.5 Guardtime Federal Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst